- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02383329
Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight (MIntS)
The purpose of this study is to test whether the provision of ONS to malnourished children across Europe, in addition to standard counselling, will improve weight gain and other outcomes.
The hypothesis to be tested is:
• Supplementation with ONS in malnourished paediatric patients will lead to increased WFH gain, as well as less malnutrition related complications (e.g. infections).
Primary outcome • The change in BMI z-score over the intervention period of 3 months
Secondary outcomes
• The change in WFH-weight for height (z-scores) over the intervention period of 3 months
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussel, Belgium
- UZ Brussel
-
-
-
-
-
Zagreb, Croatia
- Children's Hospital Zagreb
-
-
-
-
-
Lille, France
- Hospital Jeanne de Flandre, Pediatrics Department, CHRU
-
Tours, France, 37000
- CHU Tours
-
-
-
-
-
Athens, Greece
- Agia Sofia Children's Hospital
-
Thessaloniki, Greece, 54124
- Aristotle University Of Thessaloniki, School of Medicine
-
Thessaloniki, Greece
- 1st Paediatric Dept, Hippokration Hospital, AUTH
-
Thessaloniki, Greece
- 3rd Paediatric Dept, Hippokration Hospital, AUTH
-
-
-
-
-
Tehran, Iran, Islamic Republic of, 1419733151
- Tehran University of Medical Sciences Tehrān, Children Medical Center
-
Tehran, Iran, Islamic Republic of
- Mofid Children Hospital
-
-
-
-
-
Oslo, Norway
- Department of Pediatrics, Women and Children's Division, Oslo University Hospital
-
-
-
-
-
Warszawa, Poland, 01-184
- Medical University of Warsaw
-
Warszawa, Poland, 04-730
- The Children's Memorial Health Institute
-
-
-
-
-
Moscow, Russian Federation, 125480
- Russian Medical Academy of Postgraduate Education
-
-
Respublika Tatarstan
-
Kazan, Respublika Tatarstan, Russian Federation, 420012
- Kazan State Medical University
-
-
-
-
-
Ankara, Turkey
- Ankara University School of Medicine
-
Ankara, Turkey, 06100
- Hacettepe University, Ankara
-
Inönü, Turkey
- Inönü University School of Medicine
-
-
Inciralti-izmir
-
Izmir, Inciralti-izmir, Turkey, 35340
- Dokuz Eylul University,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children treated at the participating paediatric centres during the study period (inpatients or outpatients)
- Age between 24 months to 12 years at inclusion
- WFH at inclusion <- 1,5 SD - >-2,5 SD (based on WHO) OR Decrease in WFH z-score of ≥1 SD within the last 3 months, and underlying disease with high risk of undernutrition
- Children who would be considered candidates for oral nutrition intervention (but do not need tube feeding)
- Written informed consent of parents/caregivers
Exclusion Criteria:
- Children in need of intensive care
- Inability to consume ONS (e.g. major gastrointestinal dysfunction)
- Children, for whom normal nutrition intervention would be inappropriate (e.g. food intolerance, allergy)
- Use of parenteral feeding and/or enteral tube-feeding
- Severe edema (>0.5 cm pitting edema on the dorsum of the foot)
- Participation in another intervention study involving investigational or marketed products concomitantly or within two weeks prior to entry into the trial.
- Children having received enteral nutrition treatment for underweight in the previous month
- Oncology patients during chemo-, radio-therapy
Expected hospital stay at inclusion longer than 7 days
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Oral Nutritional Supplement (ONS)
Diet consultation for the child/family + ONS
|
The ONS provided to the children intervention group will be a ready to drink age adapted oral nutrition supplement providing 1,5 kcal/ml
|
|
No Intervention: No Oran Nutritional Supplement (ONS)
Diet consultation for the child/family
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI z-score
Time Frame: 3 months
|
The change in BMI z-score over the intervention period of 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight change
Time Frame: 3 months
|
The change in WFH-weight for height (z-scores) over the intervention period of 3 months
|
3 months
|
|
Infectious complications
Time Frame: 3 months
|
Frequency of infectious complications (number of days with temperature >38,5°C, number of infections requiring antibiotic use)
|
3 months
|
|
Hospital admissions
Time Frame: 3 months
|
Admission for hospital inpatient treatments (number of days of hospital stay, number of admissions)
|
3 months
|
|
Gastrointestinal complications
Time Frame: 3 months
|
Frequency of gastrointestinal complications (number of days with diarrhoea/vomiting as reported by carers).
Other GI symptoms could be recorded, as potential reason for lower food intake
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Chourdakis, MD PhD, AUTH
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AUTh112Med
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disease Associated Underweight
-
National Institute of Public Health, CambodiaEmory University; World Vision International; World Vision, Hong Kong; World Vision...CompletedUnderweight Children Aged 6-23 Month Old (WAZ < -1)Cambodia
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness | UnderweightBrazil
-
KK Women's and Children's HospitalNational Medical Research Council (NMRC), Singapore; Duke-NUS Graduate Medical... and other collaboratorsCompleted
-
University of Campinas, BrazilFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of GhanaUniversity of Glasgow; University of StirlingCompletedHealthy | Stunting | UnderweightGhana
-
Karaman Training and Research HospitalCompletedPreoperative FastingTurkey (Türkiye)
-
Universidad de CuencaUniversidad de AntioquiaCompletedObesity | Overweight | UnderweightEcuador
-
Bill & Melinda Gates Medical Research InstituteTerminatedUnderweight | PaediatricsPakistan
-
Institut Pertanian BogorAjinomoto Co., Inc.UnknownAnemia | Stunting | UnderweightIndonesia
-
HRI-MAIL-NITEnrolling by invitationMASLD | Metabolic Dysfunction-Associated Steatotic Liver Disease | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) | MetALDUnited States